2003

First to introduce Advanced Delivery Technology (ADT) needleless vaccine delivery to avoid accidental injection of intranasal canine cough vaccines—Nobivac^® Intra-Trac^® ₃ ADT

2005

First USDA-approved canine distemper, adenovirus (Hepatitis), parvovirus (DAP) vaccine with 3-year DOI—Nobivac^® Canine 3-DAPv

2006

First USDA-approved feline rhinotracheitis, calicivirus and panleukopenia virus (HCP) vaccine with a 3-year DOI—Nobivac® Feline 3-HCP

2008

Published first data demonstrating protection with our canine range against parvovirus 2c strain

2009

First to develop a Lyme vaccine, Nobivac^® Lyme, that induced borreliacidal antibodies to outer surface protein C

First canine influenza (H3N8) vaccine with Nobivac^® Canine Flu H3N8

2010

First company to provide a FeLV vaccine with a 2-year DOI with Nobivac^® Feline 2-FeLV

2011

First leptospirosis vaccine, Nobivac^® Lepto₄, with label claims against mortality and urinary shedding caused by serovars L. canicola, L. grippotyphosa, L. icterohaemorrhagiae and L. pomona

Introduced VacciPure™ filtration advancement to Nobivac^® Lepto₄

2016

Launched first bivalent canine influenza vaccine protecting against both CIV H3N2 and CIV H3N8 with Nobivac^® Canine Flu Bivalent

2018

First canine influenza vaccine to include protection for felines

2019

Introduced first low-volume range of vaccines, which includes parainfluenza—Nobivac EDGE^® DAPPv, Nobivac EDGE^® Lepto₄ and Nobivac EDGE^® DAPPv+L₄